Pharmaceutical Development Partners

Call
Website
316 Wall St
Princeton, NJ 08540
+1 (609) 688-8900
http://pharmadvisors.com

Pharmaceutical Development Partners, based in Princeton, NJ, specializes in supporting drug development and commercialization for early-stage companies without requiring them to expand their infrastructure. Founded in 2001, the company leverages a diverse network of experienced Advisor Associates to provide targeted expertise across various aspects of CMC, regulatory strategy, quality assurance, and supply chain management.

With a focus on a flexible and efficient business model, the team offers both hands-on execution and advisory services tailored to meet the specific needs of each client. Their extensive experience with IND, NDA, BLA, and MAA submissions enables them to effectively help clients navigate the complexities of drug development while minimizing costs and managing risks.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Vitamin, nutrient, and hematinic preparations for human use

Abeille Pharmaceuticals Inc

Abeille Pharmaceuticals Inc is a research-driven company based in Princeton, NJ, specializing in the development of innovative pharmaceutical products. With a focus on cutting-edge technology and scientific advancements, Abeille Pharmaceuticals Inc is dedicated to improving healthcare outcomes for patients worldwide. Committed to excellence in drug discovery and development, Abeille Pharmaceuticals Inc collaborates with leading experts in the field to bring novel therapies to market. Through a combination of expertise and strategic partnerships, the company strives to address unmet medical needs and make a meaningful impact on global health. Generated from their business information
Nonresidential construction, nec, nec, Drugs and drug proprietaries

Vioquest Pharmaceuticals Inc

Vioquest Pharmaceuticals Inc. is a biotechnology company based in Monmouth Junction, NJ, focusing on the development of innovative therapeutic solutions for autoimmune diseases. With a strong emphasis on research and preclinical development, the company is advancing its pipeline of drug candidates, including PV-3212, aimed at treating multiple sclerosis and other autoimmune conditions. The company is dedicated to exploring MHC II inhibition and developing inhibitors targeting diseases such as Goodpasture's syndrome and Parkinson's. Vioquest Pharmaceuticals also provides drug discovery services supported by expert medicinal chemistry and therapeutic expertise to facilitate client-driven projects. Generated from the website
Drugs and drug proprietaries

Novo Nordisk Pharmaceuticals

Novo Nordisk Pharmaceuticals, headquartered in Princeton, NJ, is a global leader in the development of innovative medicines, particularly in the fields of obesity and cardiometabolic diseases. The company is committed to redefining obesity care and advancing treatment options through scientific research and collaboration. With a strong focus on sustainable business practices, Novo Nordisk aims to improve patient outcomes while maintaining a robust pipeline of products. The company continues to expand its reach and impact in the healthcare sector, reflecting its dedication to addressing pressing medical needs. Generated from the website
United States›New Jersey›Princeton›Pharmaceutical Development Partners